2. What are General Anesthetics?
• A drug that brings about a reversible loss of
consciousness
• generally administered by an
anesthesiologist in order to induce or
maintain general anesthesia to facilitate
surgery.
intravenous anaesthetic agents/anesthesiology/184-244 2
3. Routes for Delivery of General
Anesthetics
• Intravenous (IV)
• Inhalational
intravenous anaesthetic agents/anesthesiology/184-244 3
5. Types of General Anesthetics
• Induction agents
• Induction agents usually administered IV
• can be inhalational for those who do not tolerate IV access
• Maintenance agents
• Maintenance agents usually administered inhalationally or IV with bolus
or continuous infusion technique
intravenous anaesthetic agents/anesthesiology/184-244 5
6. Structural formulas of anesthetic drugs
intravenous anaesthetic agents/anesthesiology/184-244 6
8. Intravenous Anaesthetics
• Primary role as induction agents
• Maintenance with total intravenous anesthesia
• Rapid redistribution
• Shorter half lives
• Environmental risk of inhalational agents
• Rapid distribution to vessel rich tissue
intravenous anaesthetic agents/anesthesiology/184-244 8
9. Intravenous Anaesthetics
• High lipid solubility allows for rapid induction
• When redistributed out of the brain, effect
decreases
• Advantages
• Rapid and complete induction
• Less CV depression
intravenous anaesthetic agents/anesthesiology/184-244 9
10. Intravenous Anaesthetics
• Most exert their actions by potentiating GABAA receptor
• GABAergic actions may be similar to those of volatile
anesthetics, but act at different sites on receptor
intravenous anaesthetic agents/anesthesiology/184-244 10
11. Intravenous Anaesthetics
• Most decrease cerebral metabolism and
intracranial pressure
• Most cause respiratory depression
• May cause apnea after induction of anesthesia
• Barbiturates, benzodiazepines and propofol
cause cardiovascular depression
intravenous anaesthetic agents/anesthesiology/184-244 11
12. Benzodiazepines
Rarely used alone for general anesthesia
• Cannot easily induce and maintain general anesthesia
• Lack analgesic properties
Used for sedative and amnestic effects
intravenous anaesthetic agents/anesthesiology/184-244 12
13. Benzodiazepines (Diazepam, Midazolam)
Indications:
1. Sedation during regional anesthesia
2. Radiological procedures (children, anxious persons)
3. Endoscopy
4. ICU
5. Supplementation to general anesthesia
6. Amnesia
7. Status epilepticu
intravenous anaesthetic agents/anesthesiology/184-244 13
14. Benzodiazepines (Diazepam, Midazolam)
Adverse effects:
1. Prolong duration (diazepam)
2. Painful on injection (diazepam)
3. Hypotension if used with other agents like opioids
4. Dependence
5. Respiratory depression in over dosage
Contraindications:
Early pregnancy (teratogenic effect)
intravenous anaesthetic agents/anesthesiology/184-244 14
16. Barbiturates (thiopenton or thiopental)
• greater potency,
• more rapid onset of action, and shorter durations
• of action (after a single “sleep dose”)
• Effect terminated not by metabolism but by
redistribution
intravenous anaesthetic agents/anesthesiology/184-244 16
17. Barbiturates (thiopenton or thiopental)
Indications:
1. Induction of anesthesia
2. Maintenance of anesthesia (but has cumulative effects)
3. Treatment of status epilepticus
4. Reduction of intra-cranial pressure (ICP)
intravenous anaesthetic agents/anesthesiology/184-244 17
18. Adverse effects:
1. Hypotension
2. Respiratory depression
3. Tissue necrosis (if injected extra-vascular)
4. Laryngospasm
5. Bronchospasm (avoid in asthma)
6. Thrombophlibitis (less common in 2.5% conc.)
7. Allergic reactions 1 in 14000-20000
8. Intra-arterial injection (lead to sever
vasospasm and sever pain it may lead to
gangrene of the limb, treatment by keeping the
cannula in and inject papeverine 20 mg,
heparin and fluid, using 2.5% conc. Is safer)
intravenous anaesthetic agents/anesthesiology/184-244 18
19. Contra indications:
1. Airway obstruction (epiglottis or pharyngeal
tumours)
2. Porphyria
3. Previous hypersensitivity to this drug
intravenous anaesthetic agents/anesthesiology/184-244 19
21. Indications:
• Induction of anesthesia when rapid early recovery of
consciousness is indicated
• Sedation during regional anesthesia
• Sedation in ICU
• Total intravenous anesthesia
Adverse effects:
• Cardiovascular depression
• Respiratory depression
• Excitatory phenomena (convulsion, myoclonus)
• Pain on injection
• Allergic reaction
Contra indication:
• Airway obstruction
• Hypersensitivity
intravenous anaesthetic agents/anesthesiology/184-244 21
22. Ketamine
• NMDA Receptor Antagonist
• usually stimulate rather than depress the circulatory system
• Dissociate anaesthesia
• Analgesia
intravenous anaesthetic agents/anesthesiology/184-244 22
23. Indications:
• Shocked patient
• Paediatric anesthesia
• Difficult locations (at accident site, wars)
• Analgesia And sedation (wound dressing change)
• In ICU
• In developing countries (where anesthesia equipments and trained staff are in short
supply)
Adverse effects:
• Emergence delirium, nightmares and hallucinations
• Hypertension and tachycardia
• Prolong recovery
• Salivation
• Increase intra-cranial pressure
intravenous anaesthetic agents/anesthesiology/184-244 23
24. Etomidate
Indications:
• Used in patient with cardiovascular disease (cardiovascular
stable)
• Suitable for out patient anesthesia
intravenous anaesthetic agents/anesthesiology/184-244 24
25. Adverse effects:
• Excitatory phenomena (involuntary movements,
hiccups, cough)
• Pain on injection
• Nausea and vomiting
• Venous thrombosis
Contraindications:
• Airway obstruction
• Porphyria
• Adrenal insufficiency
• Long term duration
intravenous anaesthetic agents/anesthesiology/184-244 25
27. MINIMUM ALVEOLAR CONCENTRATION
(MAC)
• The minimum alveolar concentration of an
inhaled anesthetics is the alveolar concentration
that prevents movement in 50% of patient in
response to a standardized stimulus (e.g.
Surgical Incision)
intravenous anaesthetic agents/anesthesiology/184-244 27
28. MINIMUM ALVEOLAR
CONCENTRATION (MAC)
DEF: The minimum alveolar concentration of an
inhaled anesthetics is the alveolar concentration
that prevents movement in 50% of patient in
response to a standardized stimulus (e.g.
Surgical Incision)
intravenous anaesthetic agents/anesthesiology/184-244 28
29. MAC VALUE OF INHALATION
ANESTHETICS AGENTS
• Nitrous oxide: 105%
• Halothane: 0.75%
• Isoflurane : 1.2%
• Desflurane: 6%
• Sevoflurane: 2%
intravenous anaesthetic agents/anesthesiology/184-244 29
31. NITROUS OXIDE
Physical properties:
It is a laughing gas.
It is only inorganic anesthetic gas in clinical use.
Colorless and odorless
Non Explosive and Non Infammable
Gas at room temperature and can be kept as a
liquid under pressure.
It is relatively inexpensive.
intravenous anaesthetic agents/anesthesiology/184-244 31
32. Effects of Nitrous Oxide on Organ
System
1. CARDIOVASCULAR SYSTEM
• Stimulate sympathetic nervous system.
• Directly depresses myocardial contractility.
• Arterial blood pressure ,heart rate and cardiac
output are slightly increased.
2. RESPIRATORY SYSTEM:
• Increases respiratory rate with decreases tidal volume.
• Minimal change in minute ventilation.
intravenous anaesthetic agents/anesthesiology/184-244 32
33. 3. CEREBRAL:
• Increases CBF thus increasing intracranial pressure.
4. RENAL SYSTEM:
• It decreases renal blood flow thus leads to drop in
glomerular filtration rate and urinary output.
5. HEPATIC SYSTEM:
• Decreases the Hepatic blood flow but to a lesser extent
than other inhalation agents.
6. GASTROINTESTINAL:
• It causes post operative Nausea and Vomiting.
intravenous anaesthetic agents/anesthesiology/184-244 33
36. HALOTHANE
• Physical Properties:
• It is halogenated alkene.
• Non Inflammable and Non explosive.
• Least expensive .
intravenous anaesthetic agents/anesthesiology/184-244 36
37. EFFECTS ON ORGAN SYSTEM
1. CARDIOVASCULAR:
Dose dependent reduction of arterial blood pressure by direct
myocardial depression.
It is a coronary artery vasodilator.
It causes slowing of SA node conduction resulting in
bradycardia.
2. RESPIRATORY SYSTEM:
Causes rapid ,shallow breathing.
Decrease in alveolar ventilation and Paco2 elevated.
Potent dronchodilator.
intravenous anaesthetic agents/anesthesiology/184-244 37
39. CONTRAINDICATION
• Unexplained liver dysfunction.
• Intra-cranial mass lesions.
• Hypo-volemic patient with severe cardiac
diseases.
intravenous anaesthetic agents/anesthesiology/184-244 39
40. ISOFLURANE
It is non flammable volatile with a pungent smell.
EFFECTS ON ORGAN SYSTEM:
1. CARDIOVASCULAR:
Causes minimal cardiac depression.
Rapid increase in MAC lead to increase in HR and BP.( Coronary
Steal)
Dilates coronary arteries.
2. RESPIRATORY SYSTEM:
Respiratory depression .
Acts as a good bronchodilator.
intravenous anaesthetic agents/anesthesiology/184-244 40
41. 3. CEREBRAL:
If con> 1 MAC causes increase in CBF and
Intracranial pressure.
4. NEUROMUSCULAR:
Relaxes skeletal muscles.
5. RENAL:
Decreases renal blood flow , glomerular filtration
rate and urinary output.
6. HEAPTIC:
Reduces hepatic blood flow.
INDICATIONS- For Cardiac and Neuro- Surgery
intravenous anaesthetic agents/anesthesiology/184-244 41
42. CONTRAINDICATION
• No such contraindication.
• Patient with severe hypovolemia may not tolorate its
vasodilating effects.
intravenous anaesthetic agents/anesthesiology/184-244 42
43. DESFLURANE
Structure much similar to that of isoflurane.
Recovery time are approximately 50 % less than those of
Isoflurane. Pungent Smell
TEC 6
EFFECTS ON ORGAN SYSTEM:
1. CARDIOVASCULAR SYSTEM:
Similar to Isoflurane( Increases HR and BP when increased
MAC rapidly)
Dilates coronary arteries.
intravenous anaesthetic agents/anesthesiology/184-244 43
44. 2. RESPIRATORY SYSTEM:
• Causes decrease in tidal volume and increase in
resp rate.
• Pungency and airway irritation so causes
coughing and sometime bronchospasm.
3. CEREBRAL:
• Increases CBF and Intracranial pressure.
4. NEUROMUSCULAR:
• Relaxes skeletal muscle.
5. RENAL AND HEPATIC SYSTEM:
• No any evidence has been documented.
INDICATION- For Hepatic and Renal Surgery
intravenous anaesthetic agents/anesthesiology/184-244 44